...
首页> 外文期刊>癌と化学療法 >Effective treatment with the additional administration of UFT for refractory malignant pleural effusion secondary to adenocarcinoma of the lung after the treatment regimen of gemcitabine and vinorelbine
【24h】

Effective treatment with the additional administration of UFT for refractory malignant pleural effusion secondary to adenocarcinoma of the lung after the treatment regimen of gemcitabine and vinorelbine

机译:在吉西他滨和血岭治疗方案后,用额外的UFT施用尿布抗难治性胸腔积液的难治性恶性胸腔积液的治疗

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

The patient was a 71-year-old man with pleural effusion secondary to adenocarcinoma of the lung. Systemic chemotherapy with gemcitabine (GEM) and vinorelbine (VNR) was administered. This treatment brought a decrease in pleural effusion. After three cycles of the regimen with GEM and VNR, the regimen was changed to weekly paclitaxel. However, the paclitaxel regimen was not effective. Therefore, we returned to the former regimen. However, the pleural effusion was refractory to that regimen, and increased. We then added 5-FU to the regimen. This addition again brought a decrease in the pleural effusion, suggesting that the additional administration of UFT is effective against refractory malignant pleural effusion after the treatment regimen with GEM and VNR.
机译:患者是一个71岁的男性,胸膜腺癌继发于肺癌。 施用与吉西众红滨(宝石)和血管链(VNR)的全身化学疗法。 这种治疗使胸腔积液降低。 在用宝石和VNR方案的三个周期之后,方案改变为每周紫杉醇。 然而,紫杉醇方案无效。 因此,我们返回前革命。 然而,胸腔积液对该方案具有难治性,并且增加。 然后我们加入了5-Fu的方案。 此外再次引起胸腔积液的降低,表明额外的UTT施用在治疗方案与GEM和VNR的治疗方案后有效抗难治性恶性胸腔积液。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号